162 related articles for article (PubMed ID: 26636714)
1. Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer.
Dai X; Fan W; Wang Y; Huang L; Jiang Y; Shi L; Mckinley D; Tan W; Tan C
Mol Pharm; 2016 Feb; 13(2):520-33. PubMed ID: 26636714
[TBL] [Abstract][Full Text] [Related]
2. Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery.
Fan W; Wang Y; Dai X; Shi L; Mckinley D; Tan C
Pharm Res; 2015 Apr; 32(4):1325-40. PubMed ID: 25319102
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
4. Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.
Yung BC; Li J; Zhang M; Cheng X; Li H; Yung EM; Kang C; Cosby LE; Liu Y; Teng L; Lee RJ
Mol Pharm; 2016 Feb; 13(2):653-62. PubMed ID: 26741162
[TBL] [Abstract][Full Text] [Related]
5. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
6. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment.
Fei BY; Wang XY; Fang XD
Tumour Biol; 2016 May; 37(5):5829-35. PubMed ID: 26581910
[TBL] [Abstract][Full Text] [Related]
8. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel.
Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S
Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124
[TBL] [Abstract][Full Text] [Related]
9. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
[TBL] [Abstract][Full Text] [Related]
10. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
[TBL] [Abstract][Full Text] [Related]
11. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiproliferative and apoptosis effect of paclitaxel-loaded polymeric micelles against non-small cell lung cancers.
Zhang XY; Zhang YD
Tumour Biol; 2015 Jul; 36(7):4949-59. PubMed ID: 25702089
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
Wang YY; Ren T; Cai YY; He XY
Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer.
Wu X; Liu T; Fang O; Dong W; Zhang F; Leach L; Hu X; Luo Z
Oncotarget; 2016 Jan; 7(3):2417-32. PubMed ID: 26678031
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
18. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
19. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
20. Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy.
Dai X; Jiang Y; Tan C
PLoS One; 2015; 10(5):e0126653. PubMed ID: 25946136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
